BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 26627449)

  • 1. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of a public health department's expansion from a one-step to a two-step refugee screening process on the detection and initiation of treatment of latent tuberculosis.
    Einterz EM; Younge O; Hadi C
    Public Health; 2018 Jun; 159():27-30. PubMed ID: 29698931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities for screening and treatment of latent tuberculosis infection in the United States.
    Linas BP; Wong AY; Freedberg KA; Horsburgh CR
    Am J Respir Crit Care Med; 2011 Sep; 184(5):590-601. PubMed ID: 21562129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Screening and Treating Foreign-Born Students for Tuberculosis before Entering the United States.
    Wingate LT; Coleman MS; Posey DL; Zhou W; Olson CK; Maskery B; Cetron MS; Painter JA
    PLoS One; 2015; 10(4):e0124116. PubMed ID: 25924009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?
    Jazwa A; Coleman MS; Gazmararian J; Wingate LT; Maskery B; Mitchell T; Weinberg M
    Vaccine; 2015 Mar; 33(11):1393-9. PubMed ID: 25595868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis among Newly Arrived Immigrants and Refugees in the United States.
    Liu Y; Phares CR; Posey DL; Maloney SA; Cain KP; Weinberg MS; Schmit KM; Marano N; Cetron MS
    Ann Am Thorac Soc; 2020 Nov; 17(11):1401-1412. PubMed ID: 32730094
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease Surveillance Among U.S.-Bound Immigrants and Refugees - Electronic Disease Notification System, United States, 2014-2019.
    Phares CR; Liu Y; Wang Z; Posey DL; Lee D; Jentes ES; Weinberg M; Mitchell T; Stauffer W; Self JL; Marano N
    MMWR Surveill Summ; 2022 Jan; 71(2):1-21. PubMed ID: 35051136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Usemann J; Ledergerber M; Fink G; Ritz N
    Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
    Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
    Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Analysis of the Impact of Overseas and Domestic Treatment and Screening Options for Intestinal Helminth Infection among US-Bound Refugees from Asia.
    Maskery B; Coleman MS; Weinberg M; Zhou W; Rotz L; Klosovsky A; Cantey PT; Fox LM; Cetron MS; Stauffer WM
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004910. PubMed ID: 27509077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.
    Pépin J; Desjardins F; Carignan A; Lambert M; Vaillancourt I; Labrie C; Mercier D; Bourque R; LeBlanc L
    PLoS One; 2022; 17(5):e0267781. PubMed ID: 35587499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013.
    Marks SM; Woodruff RY; Owusu-Edusei K; Asay GRB; Hill AN
    Public Health Rep; 2019; 134(5):522-527. PubMed ID: 31339816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
    Dara M; Solovic I; Sotgiu G; D'Ambrosio L; Centis R; Tran R; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Bothamley G; Schaberg T; Abubakar I; Teixeira V; Ward B; Gratziou C; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):808-17. PubMed ID: 27492827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups.
    Auguste P; Tsertsvadze A; Court R; Pink J
    Tuberculosis (Edinb); 2016 Jul; 99():81-91. PubMed ID: 27450009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.